Publications by authors named "Jason Deng"

Claim this Profile
H
Highly Selective Novel Heme Oxygenase-1 Hits Found by DNA-Encoded Library Machine Learning beyond the DEL Chemical Space.
Shuai Han, Xinyun Guo, Min Wang, Huan Liu, Yidan Song, Jason Deng

ACS Med Chem Lett· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling cells with DELs: Small molecule fingerprinting of cell surfaces.
Jason Deng, Svetlana Belyanskaya, Ninad Prabhu, Christopher Arico-Muendel, Hongfeng Deng

SLAS Discov· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DELs enable the development of BRET probes for target engagement studies in cells.
Kelly A Teske, Wenji Su, Cesear R Corona, Jing Wen, Jason Deng

Cell Chem Biol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of AI-Based Protein Structure Prediction for the NLRP3 Target.
Jian Yin, Junkun Lei, Jialin Yu, Weiren Cui, Alexander L Satz, Jason Deng

Molecules· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMPL: A Data-Driven Modeling Pipeline for Drug Discovery.
Amanda J Minnich, Kevin McLoughlin, Margaret Tse, Jason Deng, Andrew Weber

J Chem Inf Model· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multi-RNAi Microsponge Platform for Simultaneous Controlled Delivery of Multiple Small Interfering RNAs.
Young Hoon Roh, Jason Z Deng, Erik C Dreaden, Jae Hyon Park, Dong Soo Yun

Angew Chem Int Ed Engl· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodegradable nano-films for capture and non-invasive release of circulating tumor cells.
Wei Li, Eduardo Reátegui, Myoung-Hwan Park, Steven Castleberry, Jason Z Deng

Biomaterials· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER).
Eun-Ae Cho, Fergal J Moloney, Hong Cai, Annie Au-Yeung, Carlos China, Jason Z Deng

Lancet· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis